Melissa B. Epperly - 15 Jun 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jun 2022, 20:03:42 UTC
Prior SEC filing
15 Jun 2022
Next SEC filing
11 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew B. Murphy, as Attorney-in-Fact

Key filing fact

Melissa B. Epperly filed Form 4 for Nautilus Biotechnology, Inc. (NAUT) on 16 Jun 2022.

Key facts

  • This page summarizes Melissa B. Epperly's Form 4 filing for Nautilus Biotechnology, Inc. (NAUT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 16 Jun 2022, 20:03.

Change

  • Previous filing in this sequence was filed on 15 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NAUT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+86,467
Change %
Price
$0.000000
Shares after
86,467
Date
15 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
86,467
Exercise price
$2.70
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .